HON three-lens brief
Evidence-based stock research on HON. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 15.9pp over 30 days. · Debt-to-equity of 250.5 — balance-sheet-heavy.
- Underperforming SPY by 15.9pp over 30 days.
- Analyst mean target $251.70 — 18% above current (25 analysts).
- Debt-to-equity of 250.5 — balance-sheet-heavy.
HON closed at $213.17 (-0.55%) as of 2026-04-25. Market cap: $135.08B. P/E (trailing) 34.0. Positives: analyst mean target $251.70 — 18% above current (25 analysts).. Concerns: underperforming SPY by 15.9pp over 30 days.; debt-to-equity of 250.5 — balance-sheet-heavy.. Last quarter: Revenue $9.14B, net income $821.00M, free cash flow $3.10B.
Why three lenses on HON, not one.
A single reasoning model has blind spots it doesn’t know about. We examine HONacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/HON" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath HON brief"></iframe>